Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 7Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Turcot syndrome 1Pathologic Complete Response 1Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 11toripalimab 8Capecitabine 8Gemcitabine 6Fluorouracil 5tislelizumab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3sintilimab 2anlotinib 2Taxes 2Radiation 2Drug Therapy 2spartalizumab 1pembrolizumab 1palbociclib 1nedaplatin 1lobaplatin 1camrelizumab 1Valganciclovir 1Therapeutics 1Taurine 1Sodium Fluoride 1Single Person 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leyk 1LY-2157299 1Induction Chemotherapy 1Docosahexaenoic Acids 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Carcinoma × Induction Chemotherapy × Clear all
NCT05622474 2022-11-18

A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy

Sun Yat-sen University

Phase NA Not yet recruiting
236 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡